Zigang Li

3.3k total citations
95 papers, 2.0k citations indexed

About

Zigang Li is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Zigang Li has authored 95 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Molecular Biology, 34 papers in Organic Chemistry and 23 papers in Oncology. Recurrent topics in Zigang Li's work include Chemical Synthesis and Analysis (41 papers), Click Chemistry and Applications (23 papers) and Peptidase Inhibition and Analysis (18 papers). Zigang Li is often cited by papers focused on Chemical Synthesis and Analysis (41 papers), Click Chemistry and Applications (23 papers) and Peptidase Inhibition and Analysis (18 papers). Zigang Li collaborates with scholars based in China, United States and Hong Kong. Zigang Li's co-authors include Chuan He, Feng Yin, Ronald Rahaman, David A. Capretto, Xing Jian, Dongyuan Wang, Shang‐Dong Yang, Shengdong Zhang, Hang Zhou and Yixiang Jiang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Zigang Li

89 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zigang Li China 24 949 776 316 215 197 95 2.0k
Julian M. W. Chan United States 29 445 0.5× 1.1k 1.4× 173 0.5× 178 0.8× 562 2.9× 46 2.3k
Seah Ling Kuan Germany 25 841 0.9× 616 0.8× 56 0.2× 263 1.2× 361 1.8× 62 1.6k
Yugang Bai China 21 815 0.9× 816 1.1× 101 0.3× 46 0.2× 341 1.7× 52 1.6k
Vu Hong United States 11 1.6k 1.7× 1.6k 2.0× 157 0.5× 196 0.9× 158 0.8× 11 2.5k
Laura Polito Italy 22 758 0.8× 492 0.6× 87 0.3× 80 0.4× 248 1.3× 61 1.6k
Wenying Zhong China 28 1.0k 1.1× 297 0.4× 226 0.7× 265 1.2× 666 3.4× 88 2.2k
Riddha Das United States 20 870 0.9× 501 0.6× 130 0.4× 65 0.3× 341 1.7× 22 1.9k
Samy Cecioni France 24 1.5k 1.6× 1.1k 1.4× 104 0.3× 78 0.4× 164 0.8× 33 2.0k
Eylon Yavin Israel 23 1.4k 1.4× 227 0.3× 104 0.3× 281 1.3× 62 0.3× 59 1.9k
Sébastien Vidal France 34 2.4k 2.5× 2.3k 3.0× 149 0.5× 108 0.5× 306 1.6× 103 3.7k

Countries citing papers authored by Zigang Li

Since Specialization
Citations

This map shows the geographic impact of Zigang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zigang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zigang Li more than expected).

Fields of papers citing papers by Zigang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zigang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zigang Li. The network helps show where Zigang Li may publish in the future.

Co-authorship network of co-authors of Zigang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zigang Li. A scholar is included among the top collaborators of Zigang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zigang Li. Zigang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nie, Zhiwei, Yutian Liu, Zhihong Liu, et al.. (2025). Predicting protein stability changes upon mutations with dual-view ensemble learning from single sequence. Briefings in Bioinformatics. 26(4).
2.
Wang, Dongyuan, Yajing Liu, Ying Chen, et al.. (2025). EGFR Targeted Liposomal PROTAC Assisted With Epigenetic Regulation as an Efficient Strategy for Osimertinib‐Resistant Lung Cancer Therapy. Advanced Science. 12(43). e10197–e10197. 2 indexed citations
3.
Xing, Yun, et al.. (2025). Peptides: potential delivery systems for mRNA. RSC Chemical Biology. 6(5). 666–677. 1 indexed citations
4.
Chen, Hong-Xuan, Yudong Qiu, Wu Fu, et al.. (2025). Single-molecule direct RNA sequencing reveals the shaping of epitranscriptome across multiple species. Nature Communications. 16(1). 5119–5119. 10 indexed citations
5.
Zhang, Yaping, Chenshan Lian, Yun Xing, et al.. (2024). Sulfonium‐Stapled Peptides‐Based Neoantigen Delivery System for Personalized Tumor Immunotherapy and Prevention. Advanced Science. 11(24). e2307754–e2307754. 12 indexed citations
6.
Liu, Jianbo, Zi‐You Tian, Chuan Wan, et al.. (2024). In‐Depth Structural Analysis of a Stapled Pentapeptide and Its Assembly Into Straight α‐Helices. Small. 21(4). e2406214–e2406214. 1 indexed citations
7.
Zhang, Haisheng, Xiansong Wang, Weifeng Yang, et al.. (2024). N6‐Methyladenosine Regulates Cilia Elongation in Cancer Cells by Modulating HDAC6 Expression. Advanced Science. 12(2). e2408488–e2408488. 3 indexed citations
8.
Li, Xi, et al.. (2024). Peptide Nanocarriers for Targeted Delivery of Nucleic Acids for Cancer Therapy. Bioconjugate Chemistry. 36(1). 25–33. 3 indexed citations
9.
Chen, Zhuojia, Jiawang Zhou, Feng Chen, et al.. (2024). METTL3 promotes cellular senescence of colorectal cancer via modulation of CDKN2B transcription and mRNA stability. Oncogene. 43(13). 976–991. 17 indexed citations
10.
Ma, Shenhui, Tong Li, Yang Zhu, et al.. (2023). Multi‐Body Biomarker Entrapment System: An All‐Encompassing Tool for Ultrasensitive Disease Diagnosis and Epidemic Screening. Advanced Materials. 35(46). e2304119–e2304119. 15 indexed citations
11.
Liu, Zhihong, Jianbo Liu, Jiaxin Chen, et al.. (2023). Development of Lysine Crotonyl‐Mimic Probe to Covalently Identify H3K27Cr Interacting Proteins. Chemistry - A European Journal. 29(62). e202301624–e202301624. 2 indexed citations
12.
Yin, Feng, et al.. (2022). Sulfonium-Tethered Peptide. Methods in molecular biology. 2530. 169–175. 1 indexed citations
13.
Zhou, Ziyuan, Qing Pan, Xinchen Lv, et al.. (2020). Structural insights into the inhibition of bacterial RecA by naphthalene polysulfonated compounds. iScience. 24(1). 101952–101952. 11 indexed citations
14.
Wang, Dongyuan, Wenjun Li, Longjian Chen, et al.. (2019). Stabilized Peptide HDAC Inhibitors Derived from HDAC1 Substrate H3K56 for the Treatment of Cancer Stem–Like Cells In Vivo. Cancer Research. 79(8). 1769–1783. 33 indexed citations
15.
Wang, Dongyuan, et al.. (2019). Design and Synthetic Strategies for Helical Peptides. Methods in molecular biology. 2001. 107–131. 4 indexed citations
16.
Hu, Kuan, Yixiang Jiang, Wei Xiong, et al.. (2018). Tuning peptide self-assembly by an in-tether chiral center. Science Advances. 4(5). eaar5907–eaar5907. 69 indexed citations
17.
Liu, Na, Yue Ma, Dongyuan Wang, et al.. (2018). The Development of Epigenetics and Related Inhibitors for Targeted Drug Design in Cancer Therapy. Current Topics in Medicinal Chemistry. 18(28). 2380–2394. 16 indexed citations
18.
Tian, Yuan, Dongyuan Wang, Jingxu Li, et al.. (2016). A proline-derived transannular N-cap for nucleation of short α-helical peptides. Chemical Communications. 52(59). 9275–9278. 17 indexed citations
19.
Li, Jingxu, et al.. (2016). An in-tether sulfoxide chiral center influences the biophysical properties of the N-capped peptides. Bioorganic & Medicinal Chemistry. 25(6). 1756–1761. 11 indexed citations
20.
Chen, Hao, Jie Hu, Peng R. Chen, et al.. (2008). The Pseudomonas aeruginosa multidrug efflux regulator MexR uses an oxidation-sensing mechanism. Proceedings of the National Academy of Sciences. 105(36). 13586–13591. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026